US Patent 10350196 Long-acting spiro-isoxazoline formulations
Patent 10350196 was granted and assigned to Zoetis on July, 2019 by the United States Patent and Trademark Office.
Find more entities like US Patent 10350196 Long-acting spiro-isoxazoline formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
